🔎 Trials Near Me

Почетна › Бубрежен карцином (Реналноклеточен карцином) › Флорида

Клинички испитувања за Бубрежен карцином (Реналноклеточен карцином) во Флорида

31 студии за Бубрежен карцином (Реналноклеточен карцином) бараат учесници на локации во Флорида.

Градови во Флорида

Официјален текст на студијата (англиски)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, Miami
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

  • NEO-811 Florida Site, Miami
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07300241

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

  • Mayo Clinic in Florida, Jacksonville
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06265285

A Phase 1 Study of the Safety and Tolerability of CTX-10726

  • Mayo Clinic Florida, Jacksonville
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07419841

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
  • Morton Plant Hospital, Clearwater
  • и уште 11
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #48, Celebration
  • Exelixis Clinical Site #11, Gainesville
  • Exelixis Clinical Site #78, Jacksonville
  • и уште 2
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT05176483

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

  • Mayo Clinic in Florida, Jacksonville
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07285044

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Holy Cross Hospital, Fort Lauderdale
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT03866382

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

  • H. Lee Moffitt Cancer Center, Tampa
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07594106

DESTINY-PANTUMOUR04

  • Research Site, Coral Springs
  • Research Site, St. Petersburg
  • Research Site, West Palm Beach
Се регрутираНабљудувачка студија
Возраст од 18 до 130 · Сите полови · Ажурирано 25.9.2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Mayo Clinic Jacksonville, Jacksonville
  • Moffitt Cancer Center, Tampa
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT04981119

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • MDR Core Network, Boynton Beach
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT06047379

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  • Local Institution - 0177, Miami
  • Local Institution - 0126, Orlando
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07293351

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • Sylvester Comprehensive Cancer Center - Miami, Miami
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 18.9.2026 · NCT05267626

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
  • Mayo Clinic in Florida, Jacksonville
  • и уште 3
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 18.9.2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • Mayo Clinic Pharmacy, Jacksonville
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • и уште 1
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07227415

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Memorial Healthcare System, Hollywood
  • The Oncology Institute of Hope & Innovation, Lakeland
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • UF Health Cancer Institute - Gainesville, Gainesville
  • Miami Cancer Institute, Miami
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT06661720

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

  • Mayo Clinic in Florida, Jacksonville
Се регрутираФаза 1/2
Возраст 16 и постари · Сите полови · Ажурирано 20.8.2026 · NCT05269381

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Jacksonville
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 3.8.2026 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Clermont Oncology Center, Clermont
  • Mid Florida Hematology and Oncology Center, Orange City
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 29.7.2026 · NCT04198766

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

  • Mayo Clinic Jacksonville, Jacksonville
  • Moffitt Cancer Center - McKinley Drive, Tampa
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 9.7.2026 · NCT03972657

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • AdventHealth Celebration, Celebration
  • Mayo Clinic Comprehensive Cancer Center, Jacksonville
  • Florida Cancer Specialists, Sarasota
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 8.6.2026 · NCT06026410

A Study of VET3-TGI in Patients With Solid Tumors

  • University of Miami, Miami
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 7.4.2026 · NCT06444815

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

  • Mayo Clinic in Florida, Jacksonville
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 12.3.2026 · NCT06349642

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  • Mayo Clinic, Jacksonville
  • Moffitt Cancer Center, Tampa
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2025 · NCT06682793

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

  • AdventHealth Altamonte, Altamonte Springs
  • AdventHealth Celebration, Celebration
  • AdventHealth Kissimmee, Kissimmee
  • и уште 5
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2025 · NCT04510597

A Beta-only IL-2 ImmunoTherapY Study

  • Boca Raton Regional Hospital, Boca Raton
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 9.7.2025 · NCT05086692

A Study of IBI363 in Subjects with Advanced Solid Malignancies

  • Ocala Oncology Center, Ocala
  • BRCR Medical Center, Plantation
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 19.12.2024 · NCT06281678

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

  • Mayo Clinic in Florida, Jacksonville
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 25.11.2024 · NCT05824975

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

  • Moffitt Cancer Center, Tampa
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 15.11.2024 · NCT04787042

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.